SPYVLP01
/ SpyBiotech
- LARVOL DELTA
Home
Next
Prev
1 to 6
Of
6
Go to page
1
September 23, 2025
SPYVAC01: A Study of Human Cytomegalovirus (HCMV) Vaccine SPYVLP01 With and Without Adjuvants
(clinicaltrials.gov)
- P1 | N=120 | Completed | Sponsor: SpyBiotech Limited | Active, not recruiting ➔ Completed
First-in-human • Trial completion • Cytomegalovirus Infection • Infectious Disease
September 03, 2025
Preclinical Data Supporting Development of a Novel CMV Vaccine
(IDWeek 2025)
- No abstract available
Preclinical • Infectious Disease
May 15, 2025
SPYVAC01: A Study of Human Cytomegalovirus (HCMV) Vaccine SPYVLP01 With and Without Adjuvants
(clinicaltrials.gov)
- P1 | N=120 | Active, not recruiting | Sponsor: SpyBiotech Limited | Recruiting ➔ Active, not recruiting | Trial completion date: Apr 2025 ➔ Jul 2025 | Trial primary completion date: Apr 2025 ➔ Jul 2025
Enrollment closed • Trial completion date • Trial primary completion date • Cytomegalovirus Infection • Infectious Disease
April 18, 2024
SPYVAC01: A Study of Human Cytomegalovirus (HCMV) Vaccine SPYVLP01 With and Without Adjuvants
(clinicaltrials.gov)
- P1 | N=120 | Recruiting | Sponsor: SpyBiotech Limited | Not yet recruiting ➔ Recruiting
Enrollment open • Cytomegalovirus Infection • Infectious Disease
January 01, 2024
SPYVAC01: A Phase I Study of Human Cytomegalovirus (HCMV) Vaccine SPYVLP01 With and Without Adjuvants
(clinicaltrials.gov)
- P1 | N=120 | Not yet recruiting | Sponsor: SpyBiotech Limited
Trial completion date • Trial initiation date • Trial primary completion date • Cytomegalovirus Infection • Infectious Disease
November 27, 2023
SPYVAC01: A Phase I Study of Human Cytomegalovirus (HCMV) Vaccine SPYVLP01 With and Without Adjuvants
(clinicaltrials.gov)
- P1 | N=120 | Not yet recruiting | Sponsor: SpyBiotech Limited
New P1 trial • Cytomegalovirus Infection • Infectious Disease
1 to 6
Of
6
Go to page
1